Nanosonics Ltd
OTC:NNCSF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nanosonics Ltd
OTC:NNCSF
|
AU |
Nanosonics Ltd
Nanosonics Ltd. engages in the research, development, and commercialization of infection control and decontamination products and related technologies. The company is headquartered in Sydney, New South Wales and currently employs 339 full-time employees. The company went IPO on 2007-05-17. The firm's principal activities include manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. The firm is focused on research, development and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generates sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. The firm's products include trophon2, Nanosonics Auditpro, and trophon electron paramagnetic resonance (ERP). trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics Auditpro provides real-time intelligence on ultrasound probes, operators, and infection control events to manage infection prevention practices across organizations.
Nanosonics Ltd. engages in the research, development, and commercialization of infection control and decontamination products and related technologies. The company is headquartered in Sydney, New South Wales and currently employs 339 full-time employees. The company went IPO on 2007-05-17. The firm's principal activities include manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. The firm is focused on research, development and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generates sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. The firm's products include trophon2, Nanosonics Auditpro, and trophon electron paramagnetic resonance (ERP). trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics Auditpro provides real-time intelligence on ultrasound probes, operators, and infection control events to manage infection prevention practices across organizations.
Revenue Growth: Revenue reached $102.2 million for the half, up 9% versus the prior period, with growth across both recurring and capital revenue streams.
Operating Margin: Operating margin expanded by 27% to $8.5 million, driven by disciplined cost growth of just 4%.
Recurring Revenue: Recurring revenue, driven by consumables and services, increased 9%. Service and repairs grew strongly at 24%.
Installed Base Expansion: Global installed base rose to 38,080 devices, up 6%, and total unit installations jumped 20% during the half.
Upgrade Activity: Record level of upgrades in North America, mainly to trophon2, with future opportunity to move to trophon3 or through software upgrades.
CORIS Progress: CORIS commercialization is on track, with key regulatory milestones achieved and market release in the UK; broader rollout expected to start in FY '27.
Guidance Reaffirmed: Full year guidance for 8%–12% revenue growth and gross margin of 75%–77% was reaffirmed at constant currency, though FX could impact reported results.
Strong Balance Sheet: Company remains debt-free with $159.8 million in cash, supporting growth initiatives and a share buyback program.
